Osteoporosis in patients with inflammatory bowel disease

Clinical Gastroenterology and Hepatology

Volumn 4, Issue 2, 2006, Pages 152-156

  Bernstein, Charles N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; BISPHOSPHONIC ACID DERIVATIVE; C REACTIVE PROTEIN; CALCIUM; CORTICOSTEROID; ESTROGEN; ETIDRONIC ACID; FERRITIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; PHOSPHATE; RECOMBINANT PROTEIN; TESTOSTERONE; UNCLASSIFIED DRUG; VITAMIN D;

AMENORRHEA; BONE DENSITY; CALCIUM INTAKE; COLITIS; DRUG MECHANISM; DRUG TOLERANCE; DUAL ENERGY X RAY ABSORPTIOMETRY; ENTERITIS; ESTROGEN THERAPY; FRACTURE; HUMAN; OSTEOPENIA; OSTEOPOROSIS; POSTMENOPAUSE; REVIEW; RISK FACTOR; TESTOSTERONE BLOOD LEVEL;

EID: 32044471888     PISSN: 15423565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cgh.2005.10.014     Document Type: Article

References (6)

1. C.N. Bernstein W.D. Leslie M. Leboff AGA technical review osteoporosis in gastrointestinal diseases Gastroenterology 124 2003 795 841
2. C.N. Bernstein J.F. Blanchard W.D. Leslie The incidence of fractures among patients with IBD a population-based study Ann Intern Med 133 2000 795 799
3. E.V. Loftus Jr C.S. Crowson W.J. Sandborn Long-term fracture risk in patients with Crohn’s disease a population-based study in Olmsted County, Minnesota Gastroenterology 123 2002 468 475
4. T.-P. Van Staa C. Cooper L.S. Brusse Inflammatory bowel disease and the risk of fracture Gastroenterology 125 2003 1591 1597
5. J. Kanis F. Borgstrom C. De Laet Assessment of fracture risk Osteoporos Int 16 2005 581 589
6. J.S. Siffledeen R.N. Fedorak K. Siminoski Randomized trial of etidronate plus calcium and vitamin D for treatment of low bone mineral density in Crohn’s disease Clin Gastroenterol Hepatol 3 2005 122 132